Head-to-head · Value Score
CoreAge Rx vs Luvo Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Luvo Health a 66. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameLuvo Health
#263 · Grade C · Watch List
Est. first month
$249/4wk
Save ~82% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 66 — an est. $99/mo first month, with no teaser step-up baked in. Luvo Health isn't out of it: Shoppers who want a genuine oral tablet or brand-name option alongside compounded injectables, and who will read the term-length ladder rather than anchor on the 4-week price alone.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Luvo Health |
|---|---|---|
| Value Score | 93 (A+) | 66 (C) |
| Est. first month | $99/mo | $249/4wk |
| Save vs brand-name | ~89% | ~82% |
| Semaglutide | $99/mo | $249/4wk ($62/wk) injection or $279/4wk ($70/wk) tablets — drops to $45/wk (injection) on a 52-week term; brand Ozempic® also available from $1,299/4wk |
| Tirzepatide | $149/mo | $339/4wk ($85/wk) injection — drops to $67/wk on a 52-week term; brand Zepbound® also available |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Not disclosed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Luvo Health
Real published static pricing across three GLP-1 routes — injectable, oral tablet, and brand-name Ozempic®/Zepbound® — with per-week rates that drop the longer you commit.
Why it's a deal
- Full price list published openly on a static pricing page, by medication and by commitment length, with no intake or quiz required to see a number
- Three real GLP-1 routes in one place — compounded injection, compounded oral tablet, and brand-name Ozempic®/Zepbound® — rare breadth in this ranking
- Genuine per-week savings for longer commitments (e.g. tirzepatide $85/wk at 4 weeks vs $67/wk at 52 weeks), disclosed up front rather than buried
- A Longevity line (NAD+ Injection, Sermorelin) also available from $27/wk for shoppers who want more than GLP-1 on one account
- Full refund if a provider disqualifies you before medication is ordered
The fine print
- Billed per 4 weeks, not per month, which is 13 charges a year rather than 12
- You are charged for the first period as soon as you complete the intake form, before a clinician has reviewed you
- The lowest per-week rates require a 52-week prepay — the 4-week, no-commitment price is meaningfully higher
- Refunds stop once medication is ordered, and for new patients with no video visit that is at intake submission
- States served are not publicly listed — confirm coverage before you sign up
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Luvo Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.